Seventy percent (260/372) of HCC patients in the database carried COPS subunit gene alterations, with highest rates in COPS5 (38%), COPS1 (20%), and COPS3/7A (12%) (Figure 7A, 7B). This evidence concerns the gene COPS3 and hepatocellular carcinoma.